545 related articles for article (PubMed ID: 10752567)
1. Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease.
Friedman JH; Factor SA
Mov Disord; 2000 Mar; 15(2):201-11. PubMed ID: 10752567
[TBL] [Abstract][Full Text] [Related]
2. Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease.
Fernandez HH; Friedman JH; Jacques C; Rosenfeld M
Mov Disord; 1999 May; 14(3):484-7. PubMed ID: 10348474
[TBL] [Abstract][Full Text] [Related]
3. Clozapine for the treatment of drug-induced psychosis in Parkinson's disease: results of the 12 week open label extension in the PSYCLOPS trial.
Factor SA; Friedman JH; Lannon MC; Oakes D; Bourgeois K;
Mov Disord; 2001 Jan; 16(1):135-9. PubMed ID: 11215574
[TBL] [Abstract][Full Text] [Related]
4. The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia.
Reddy S; Factor SA; Molho ES; Feustel PJ
Mov Disord; 2002 Jul; 17(4):676-81. PubMed ID: 12210856
[TBL] [Abstract][Full Text] [Related]
5. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
6. Quetiapine improves psychotic symptoms and cognition in Parkinson's disease.
Juncos JL; Roberts VJ; Evatt ML; Jewart RD; Wood CD; Potter LS; Jou HC; Yeung PP
Mov Disord; 2004 Jan; 19(1):29-35. PubMed ID: 14743357
[TBL] [Abstract][Full Text] [Related]
7. Treatment of psychosis in Parkinson's disease: safety considerations.
Fernandez HH; Trieschmann ME; Friedman JH
Drug Saf; 2003; 26(9):643-59. PubMed ID: 12814332
[TBL] [Abstract][Full Text] [Related]
8. Worsening of motor features of parkinsonism with olanzapine.
Molho ES; Factor SA
Mov Disord; 1999 Nov; 14(6):1014-6. PubMed ID: 10584679
[TBL] [Abstract][Full Text] [Related]
9. Clozapine prevents recurrence of psychosis in Parkinson's disease.
Factor SA; Brown D
Mov Disord; 1992; 7(2):125-31. PubMed ID: 1350059
[TBL] [Abstract][Full Text] [Related]
10. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa].
Svetel MV; Sternić NM; Filipović SR; Vojvodić NM; Kostić VS
Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232
[TBL] [Abstract][Full Text] [Related]
11. [Value of clozapine in treatment of psychotic disorder in Parkinson disease].
Abbar M; Courtet P; Castelnau D
Encephale; 1996; 22(1):53-63. PubMed ID: 8681876
[TBL] [Abstract][Full Text] [Related]
12. Clozapine: new preparation. A last resort for parkinsonian patients with psychosis.
Prescrire Int; 2002 Feb; 11(57):1-6. PubMed ID: 11985366
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's disease: the treatment of drug-induced hallucinations and psychosis.
Molho ES; Factor SA
Curr Neurol Neurosci Rep; 2001 Jul; 1(4):320-8. PubMed ID: 11898537
[TBL] [Abstract][Full Text] [Related]
14. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
15. Drug-induced psychotic symptoms in Parkinson's disease. Problems, management and dilemma.
Kuzuhara S
J Neurol; 2001 Sep; 248 Suppl 3():III28-31. PubMed ID: 11697685
[TBL] [Abstract][Full Text] [Related]
16. Use of clozapine to treat levodopa-induced psychosis in Parkinson's disease: retrospective review.
Widman LP; Burke WJ; Pfeiffer RF; McArthur-Campbell D
J Geriatr Psychiatry Neurol; 1997 Apr; 10(2):63-6. PubMed ID: 9188021
[TBL] [Abstract][Full Text] [Related]
17. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
18. Effects of newer antipsychotics on extrapyramidal function.
Tarsy D; Baldessarini RJ; Tarazi FI
CNS Drugs; 2002; 16(1):23-45. PubMed ID: 11772117
[TBL] [Abstract][Full Text] [Related]
19. Atypical antipsychotic drugs in the treatment of Parkinson's disease.
Friedman JH
J Pharm Pract; 2011 Dec; 24(6):534-40. PubMed ID: 22095576
[TBL] [Abstract][Full Text] [Related]
20. Treatment of drug-induced psychosis in Parkinson's disease with ziprasidone can induce severe dose-dependent off-periods and pathological laughing.
Schindehütte J; Trenkwalder C
Clin Neurol Neurosurg; 2007 Feb; 109(2):188-91. PubMed ID: 16949733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
